TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Beauty Health ( (SKIN) ) is now available.
On October 1, 2025, Pedro Malha will assume the role of President and CEO of The Beauty Health Company, succeeding Marla Beck, who will transition to an advisory role. Malha’s extensive experience in the healthcare and medical device sectors positions him to lead the company into its next growth phase, building on Beck’s efforts to enhance innovation and operational efficiency.
The most recent analyst rating on (SKIN) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Beauty Health stock, see the SKIN Stock Forecast page.
Spark’s Take on SKIN Stock
According to Spark, TipRanks’ AI Analyst, SKIN is a Neutral.
The overall stock score reflects significant financial challenges, including high leverage and negative profit margins. However, positive developments from the earnings call, such as improved margins and strategic debt restructuring, provide some optimism. Technical indicators suggest a bearish trend, and valuation metrics highlight ongoing financial difficulties.
To see Spark’s full report on SKIN stock, click here.
More about Beauty Health
The Beauty Health Company (NASDAQ: SKIN) operates at the intersection of medtech and beauty, offering skin health experiences through brands like Hydrafacial™, SkinStylus™, and Keravive™. The company focuses on personalizing skin health for diverse demographics, supported by a global community of estheticians and partners.
Average Trading Volume: 1,083,310
Technical Sentiment Signal: Buy
Current Market Cap: $253.7M
For a thorough assessment of SKIN stock, go to TipRanks’ Stock Analysis page.